DCO
Ducommun Incorporated
DCO has a slight edge over RKLB overall, supported by lower modeled downside and stronger fundamentals.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
DCO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Healthy |
DCO's profitability and balance sheet are currently healthy, and its revenue is stable, but its cash flow is under pressure.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
DCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.9x | $23.90 | -83% |
| Fair | 23x | $77.86 | -45% |
| Expensive | 36x | $122 | -14% |
| Current | 41x | $142 | — |
Historical ranges are pointers, not guarantees.
DCO's PE is in its expensive range at 41x.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
DCO Forward outlook
There aren't enough analyst estimates for DCO to show an outlook.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
DCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $3.44 | +$5.78 |
| Q2 2026 | -$1.75 | -167% |
| Q1 2026 | -$2.24 | -196% |
| Q4 2025 | -$2.19 | -204% |
| Q3 2025 | -$2.34 | -218% |
| Q2 2025 | $2.63 | +72% |
| Q1 2025 | $2.33 | +97% |
| Q4 2024 | $2.10 | +84% |
DCO has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
DCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $227M | +6.8% |
| Q2 2026 | $224.5M | +11% |
| Q1 2026 | $209M | +7.7% |
| Q4 2025 | $217.1M | +10% |
| Q3 2025 | $212.6M | +5.5% |
| Q2 2025 | $202.3M | +2.7% |
| Q1 2025 | $194.1M | +1.7% |
| Q4 2024 | $197.3M | +2.6% |
DCO's revenue has grown year over year for 22 quarters in a row: $227M last quarter, up 6.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +49 points |
| Q2 2026 | 13% | +4.1 points |
| Q1 2026 | 7.5% | -1 points |
| Q4 2025 | 7.8% | +2.5 points |
| Q3 2025 | -38% | -45 points |
| Q2 2025 | 8.5% | +1.4 points |
| Q1 2025 | 8.5% | +1.9 points |
| Q4 2024 | 5.3% | +0.6 points |
DCO has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over DCO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
DCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26.9M | +68% |
| Q2 2026 | $30M | +65% |
| Q1 2026 | $8.3M | +$12.3M |
| Q4 2025 | -$78.8M | -640% |
| Q3 2025 | $16M | +34% |
| Q2 2025 | $18.1M | +12499% |
| Q1 2025 | -$4M | +$2.6M |
| Q4 2024 | $14.6M | -37% |
DCO has the edge over RKLB on cash flow, with more consistent year-over-year improvement.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
DCO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +4K shares |
| 1 year | +3.9% | +581K shares |
| 3 years | +5% | +745K shares |
| 5 years | +27% | +3.3M shares |
| Available history | +32% | +3.8M shares |
DCO has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
DCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.8x | Healthy |
| Q2 2026 | 16.4x | High |
| Q1 2026 | 87.2x | High |
| Q4 2025 | 61.3x | High |
| Q2 2025 | 2.1x | Moderate |
| Q1 2025 | 2.4x | Moderate |
| Q4 2024 | 2.4x | Moderate |
| Q3 2024 | 2.6x | Moderate |
DCO's net debt is about 1.8 years of its operating earnings (EBITDA), down from 2.1 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.8 | Neutral |
| Stochastic | 13.6 | Oversold |
DCO's weekly RSI is 42 (neutral) and its Stochastic is 14 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
DCO PE vs Industrials Sector
| Metric | DCO | Sector median | Relative |
|---|---|---|---|
| PE | 41x | 24x | 72% above |
| PE % | 89 | 58 | 31 pts above |
DCO is trading at 41x earnings, a 72% premium to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
DCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $160.5 | 11% below |
| 20 week MA | $172.0 | 17% below |
| 50 week MA | $145.4 | 2% below |
| 100 week MA | $110.9 | 28% above |
| 200 week MA | $82.1 | 73% above |
DCO has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 73% above its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over DCO on trend strength, trading above more of its moving averages.
DCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $50.4 | $53.4 | +6% |
| 2021 | $53.4 | $45.8 | -14% |
| 2022 | $45.8 | $48.6 | +6.2% |
| 2023 | $48.6 | $52.1 | +7.1% |
| 2024 | $52.1 | $60.9 | +17% |
| 2025 | $60.9 | $96.5 | +59% |
| 2026 YTD | $96.5 | $142.4 | +48% |
DCO has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.